Predicting the active doses in humans from animal studies: A novel approach in oncology
- 1 August 2007
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 43 (12) , 1862-1868
- https://doi.org/10.1016/j.ejca.2007.05.011
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Compressing drug development timelines in oncology using phase '0' trialsNature Reviews Cancer, 2007
- Why is cancer drug discovery so difficult?Nature Reviews Drug Discovery, 2006
- What's wrong with our cancer models?Nature Reviews Drug Discovery, 2005
- Can the pharmaceutical industry reduce attrition rates?Nature Reviews Drug Discovery, 2004
- Clonogenic assay with established human tumour xenograftsEuropean Journal Of Cancer, 2004
- “Of mice and men”European Journal Of Cancer, 2004
- Orthotopic models of cancer for preclinical drug evaluationEuropean Journal Of Cancer, 2004
- Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trialsBritish Journal of Cancer, 2001
- Relationship Between Topotecan Systemic Exposure and Tumor Response in Human Neuroblastoma XenograftsJNCI Journal of the National Cancer Institute, 1998
- Systems for Identifying New Drugs Are Often FaultyPublished by American Association for the Advancement of Science (AAAS) ,1997